Ibuprofen Banner

Ibuprofen, the active ingredient in Ibuprofen Banner, is a nonsteroidal anti-inflammatory drug presented as an oral dosage form for oral use. It treats pain, fever and inflammation in adults and children when prescribed by a healthcare professional.

GNH USA supplies Ibuprofen Banner as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen acts systemically to reduce inflammation and relieve symptoms associated with several common conditions. - Pain: provides analgesic relief for mild to moderate musculoskeletal and dental pain. - Fever: lowers elevated body temperature in febrile states. - Inflammation: diminishes swelling in conditions such as arthritis and soft‑tissue injuries.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Rash: mild skin erythema or itching. - Elevated blood pressure: modest increase in some patients.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Renal impairment or acute kidney injury. - Hepatotoxicity: elevated liver enzymes. - Severe hypersensitivity reactions, including anaphylaxis. - Cardiovascular events such as myocardial infarction or stroke.

Before using Ibuprofen, consider the following safety measures. - Cardiovascular risk: assess history of heart disease or stroke before initiating therapy. - Gastrointestinal history: avoid in patients with active ulcers or severe gastritis. - Renal function: monitor kidney function in those with pre‑existing renal impairment. - Concomitant medications: review use of anticoagulants, other NSAIDs, or corticosteroids. - Pregnancy and lactation: discuss risks with a healthcare provider before use. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Ibuprofen may interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - High‑dose aspirin: heightened gastrointestinal toxicity. - Selective COX‑2 inhibitors: additive renal and cardiovascular risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in antihypertensive effect and renal function. - Diuretics: may enhance diuretic‑induced renal impairment. - Lithium: ibuprofen can raise lithium serum levels, necessitating monitoring.